severe disease flare. Distinguishing among these syndromes requires the expertise of rheumatologists and obstetrics-gynecology or maternal-fetal medicine physicians working together. Most information regarding pregnancy management in RMD comes from observational studies, primarily in patients with SLE and APS. There have been very few controlled trials. Data about pregnancies in rare rheumatic diseases usually derive from small case series. For these reasons, many recommendations are